SARASOTA, Fla., Oct. 13, 2004 (PRIMEZONE) -- SkyLynx Communications, Inc., a data wireless network provider (OTCBB:SKYC) for mobile and static applications, headquartered in Sarasota, FL has announced an agreement with Rural/Metro Ambulance, a leading national provider of emergency and non-emergency medical transportation services, to provide network services for Western Washington.
SkyLynx's deployment of their network will provide coverage over an extended area of the I5 corridor ranging from the northern area of Mount Vernon to the southern region of Chehalis. Rural/Metro will be using the SkyLynx network for mobile data communications to their vehicles as well as the Advanced Vehicle Location (AVL) capabilities integrated into their computer aided dispatch (CAD) system for faster response capabilities.
"We are proud to be part of the solution set offered by Rural/Metro. This represents another step in our ongoing relationship with one of the premier providers in the emergency and non-emergency transportation industry. Possessing the ability to meet the demanding needs of this industry paves the way to extend our network services to many other markets," stated Kevin Gorman, Chief Operating Officer of SkyLynx.
About SkyLynx
SkyLynx Communications, Inc. is a provider of data wireless services for vehicle tracking and data communications for mobile and static applications. Their wireless network is being deployed on a national basis and has been well received for its ability to provide broad geographic coverage cost effectively. The company's network has the ability to track vehicles is not affected by topography, buildings, trees or other hindrances to line-of-sight tracking; it has a range many times greater than that of cellular and G-3 systems; and it costs significantly less than satellite tracking.
Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.